Review



integrin α5β1 inhibitor  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    MedChemExpress integrin α5β1 inhibitor
    Integrin receptor activation induced by membrane receptor switch. A) The fluorescence microscopy of MSCs loaded on HAMA or OBNC hydrogel after different treatments. B) Relative fluorescence intensity in the whole field of view for each group. C) Relative fluorescence intensity per cell for each group (∗ symbol represents comparison with HAMA group, # symbol represents comparison with OBNC group). D) Flow cytometry was used to detect integrin αvβ1 and <t>α5β1</t> positive cells. E) Relative fluorescence intensity of each group. F) Flow cytometry was used to detect 12G10 positive cells and within integrin αvβ1 and α5β1 positive cells. G) Relative fluorescence intensity of each group, and relative proportions of 12G10 to integrins αvβ1 and α5β1. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ## P < 0.01, ### P < 0.001).
    Integrin α5β1 Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/atn-161/ATN-161/pmc13123509-562-61-78
    Average 94 stars, based on 13 article reviews
    integrin α5β1 inhibitor - by Bioz Stars, 2026-09
    94/100 stars

    Images

    1) Product Images from "Mechanically sensitized hydrogel microspheres trigger membrane receptor switch for cartilage repair"

    Article Title: Mechanically sensitized hydrogel microspheres trigger membrane receptor switch for cartilage repair

    Journal: Bioactive Materials

    doi: 10.1016/j.bioactmat.2026.03.017

    Integrin receptor activation induced by membrane receptor switch. A) The fluorescence microscopy of MSCs loaded on HAMA or OBNC hydrogel after different treatments. B) Relative fluorescence intensity in the whole field of view for each group. C) Relative fluorescence intensity per cell for each group (∗ symbol represents comparison with HAMA group, # symbol represents comparison with OBNC group). D) Flow cytometry was used to detect integrin αvβ1 and α5β1 positive cells. E) Relative fluorescence intensity of each group. F) Flow cytometry was used to detect 12G10 positive cells and within integrin αvβ1 and α5β1 positive cells. G) Relative fluorescence intensity of each group, and relative proportions of 12G10 to integrins αvβ1 and α5β1. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ## P < 0.01, ### P < 0.001).
    Figure Legend Snippet: Integrin receptor activation induced by membrane receptor switch. A) The fluorescence microscopy of MSCs loaded on HAMA or OBNC hydrogel after different treatments. B) Relative fluorescence intensity in the whole field of view for each group. C) Relative fluorescence intensity per cell for each group (∗ symbol represents comparison with HAMA group, # symbol represents comparison with OBNC group). D) Flow cytometry was used to detect integrin αvβ1 and α5β1 positive cells. E) Relative fluorescence intensity of each group. F) Flow cytometry was used to detect 12G10 positive cells and within integrin αvβ1 and α5β1 positive cells. G) Relative fluorescence intensity of each group, and relative proportions of 12G10 to integrins αvβ1 and α5β1. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ## P < 0.01, ### P < 0.001).

    Techniques Used: Activation Assay, Membrane, Fluorescence, Microscopy, Comparison, Flow Cytometry

    Related Articles

    Functional Assay:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an

    Expression Vector:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an

    Mutagenesis:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an

    Construct:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an

    Expressing:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an

    Western Blot:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an

    Mouse Assay:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an

    Recombinant:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an

    Magnetic Beads:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an

    Cell Culture:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an

    Isolation:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an

    Lysis:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an

    Co-Immunoprecipitation Assay:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an

    Immunoprecipitation:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an

    Transmission Assay:

    Article Title: A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis
    Article Snippet: harmacological inhibitors Monensin (Cat. No. HY-N4302) [ 40 ], Dynasore (Cat. No. HY-15304) [ 41 ], Edelfosine (Cat. No. HY-108610 A) [ 42 ], and ATN-161 (Cat. No. HY-13535) [ 41 ] were purchased from MedChemExpress. For functional domain analysis, a series of C1R expression vectors, including truncated plasmids (C1R-ΔCCPΔTryp and C1R-ΔCUBΔEGF) and mutant plasmids (E510R and D375R) were designed an



    Similar Products

    integrin α5β1 inhibitor  (MedChemExpress)
    94
    MedChemExpress integrin α5β1 inhibitor
    Integrin receptor activation induced by membrane receptor switch. A) The fluorescence microscopy of MSCs loaded on HAMA or OBNC hydrogel after different treatments. B) Relative fluorescence intensity in the whole field of view for each group. C) Relative fluorescence intensity per cell for each group (∗ symbol represents comparison with HAMA group, # symbol represents comparison with OBNC group). D) Flow cytometry was used to detect integrin αvβ1 and <t>α5β1</t> positive cells. E) Relative fluorescence intensity of each group. F) Flow cytometry was used to detect 12G10 positive cells and within integrin αvβ1 and α5β1 positive cells. G) Relative fluorescence intensity of each group, and relative proportions of 12G10 to integrins αvβ1 and α5β1. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ## P < 0.01, ### P < 0.001).
    Integrin α5β1 Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/atn-161/ATN-161/pmc13123509-562-61-78
    Average 94 stars, based on 1 article reviews
    integrin α5β1 inhibitor - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    atn 161  (MedChemExpress)
    94
    MedChemExpress atn 161
    Integrin receptor activation induced by membrane receptor switch. A) The fluorescence microscopy of MSCs loaded on HAMA or OBNC hydrogel after different treatments. B) Relative fluorescence intensity in the whole field of view for each group. C) Relative fluorescence intensity per cell for each group (∗ symbol represents comparison with HAMA group, # symbol represents comparison with OBNC group). D) Flow cytometry was used to detect integrin αvβ1 and <t>α5β1</t> positive cells. E) Relative fluorescence intensity of each group. F) Flow cytometry was used to detect 12G10 positive cells and within integrin αvβ1 and α5β1 positive cells. G) Relative fluorescence intensity of each group, and relative proportions of 12G10 to integrins αvβ1 and α5β1. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ## P < 0.01, ### P < 0.001).
    Atn 161, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/atn-161/ATN-161/pmc13393294-52-10-16
    Average 94 stars, based on 1 article reviews
    atn 161 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    hy 13535 cytochalasin d mce  (MedChemExpress)
    94
    MedChemExpress hy 13535 cytochalasin d mce
    Integrin receptor activation induced by membrane receptor switch. A) The fluorescence microscopy of MSCs loaded on HAMA or OBNC hydrogel after different treatments. B) Relative fluorescence intensity in the whole field of view for each group. C) Relative fluorescence intensity per cell for each group (∗ symbol represents comparison with HAMA group, # symbol represents comparison with OBNC group). D) Flow cytometry was used to detect integrin αvβ1 and <t>α5β1</t> positive cells. E) Relative fluorescence intensity of each group. F) Flow cytometry was used to detect 12G10 positive cells and within integrin αvβ1 and α5β1 positive cells. G) Relative fluorescence intensity of each group, and relative proportions of 12G10 to integrins αvβ1 and α5β1. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ## P < 0.01, ### P < 0.001).
    Hy 13535 Cytochalasin D Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/atn-161/ATN-161/pm42207635-289-112-115
    Average 94 stars, based on 1 article reviews
    hy 13535 cytochalasin d mce - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    α5β1 antagonist peptide atn 161  (Selleck Chemicals)
    93
    Selleck Chemicals α5β1 antagonist peptide atn 161
    Integrin receptor activation induced by membrane receptor switch. A) The fluorescence microscopy of MSCs loaded on HAMA or OBNC hydrogel after different treatments. B) Relative fluorescence intensity in the whole field of view for each group. C) Relative fluorescence intensity per cell for each group (∗ symbol represents comparison with HAMA group, # symbol represents comparison with OBNC group). D) Flow cytometry was used to detect integrin αvβ1 and <t>α5β1</t> positive cells. E) Relative fluorescence intensity of each group. F) Flow cytometry was used to detect 12G10 positive cells and within integrin αvβ1 and α5β1 positive cells. G) Relative fluorescence intensity of each group, and relative proportions of 12G10 to integrins αvβ1 and α5β1. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ## P < 0.01, ### P < 0.001).
    α5β1 Antagonist Peptide Atn 161, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/atn-161/ATN-161/pm41786064-149-18-24
    Average 93 stars, based on 1 article reviews
    α5β1 antagonist peptide atn 161 - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    lps ha sh  (Selleck Chemicals)
    93
    Selleck Chemicals lps ha sh
    Integrin receptor activation induced by membrane receptor switch. A) The fluorescence microscopy of MSCs loaded on HAMA or OBNC hydrogel after different treatments. B) Relative fluorescence intensity in the whole field of view for each group. C) Relative fluorescence intensity per cell for each group (∗ symbol represents comparison with HAMA group, # symbol represents comparison with OBNC group). D) Flow cytometry was used to detect integrin αvβ1 and <t>α5β1</t> positive cells. E) Relative fluorescence intensity of each group. F) Flow cytometry was used to detect 12G10 positive cells and within integrin αvβ1 and α5β1 positive cells. G) Relative fluorescence intensity of each group, and relative proportions of 12G10 to integrins αvβ1 and α5β1. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ## P < 0.01, ### P < 0.001).
    Lps Ha Sh, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/atn-161/ATN-161/pm41786064-149-12-24
    Average 93 stars, based on 1 article reviews
    lps ha sh - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    tumor bone matrix interaction  (MedChemExpress)
    94
    MedChemExpress tumor bone matrix interaction
    Integrin receptor activation induced by membrane receptor switch. A) The fluorescence microscopy of MSCs loaded on HAMA or OBNC hydrogel after different treatments. B) Relative fluorescence intensity in the whole field of view for each group. C) Relative fluorescence intensity per cell for each group (∗ symbol represents comparison with HAMA group, # symbol represents comparison with OBNC group). D) Flow cytometry was used to detect integrin αvβ1 and <t>α5β1</t> positive cells. E) Relative fluorescence intensity of each group. F) Flow cytometry was used to detect 12G10 positive cells and within integrin αvβ1 and α5β1 positive cells. G) Relative fluorescence intensity of each group, and relative proportions of 12G10 to integrins αvβ1 and α5β1. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ## P < 0.01, ### P < 0.001).
    Tumor Bone Matrix Interaction, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/atn-161/ATN-161/pmc13088306-254-11-4
    Average 94 stars, based on 1 article reviews
    tumor bone matrix interaction - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    atn-161  (MedChemExpress)
    94
    MedChemExpress atn-161
    Integrin receptor activation induced by membrane receptor switch. A) The fluorescence microscopy of MSCs loaded on HAMA or OBNC hydrogel after different treatments. B) Relative fluorescence intensity in the whole field of view for each group. C) Relative fluorescence intensity per cell for each group (∗ symbol represents comparison with HAMA group, # symbol represents comparison with OBNC group). D) Flow cytometry was used to detect integrin αvβ1 and <t>α5β1</t> positive cells. E) Relative fluorescence intensity of each group. F) Flow cytometry was used to detect 12G10 positive cells and within integrin αvβ1 and α5β1 positive cells. G) Relative fluorescence intensity of each group, and relative proportions of 12G10 to integrins αvβ1 and α5β1. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ## P < 0.01, ### P < 0.001).
    Atn 161, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/atn-161/ATN-161/custom%40hy-13535%4010%2E62347%2FDWTV3761
    Average 94 stars, based on 1 article reviews
    atn-161 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Integrin receptor activation induced by membrane receptor switch. A) The fluorescence microscopy of MSCs loaded on HAMA or OBNC hydrogel after different treatments. B) Relative fluorescence intensity in the whole field of view for each group. C) Relative fluorescence intensity per cell for each group (∗ symbol represents comparison with HAMA group, # symbol represents comparison with OBNC group). D) Flow cytometry was used to detect integrin αvβ1 and α5β1 positive cells. E) Relative fluorescence intensity of each group. F) Flow cytometry was used to detect 12G10 positive cells and within integrin αvβ1 and α5β1 positive cells. G) Relative fluorescence intensity of each group, and relative proportions of 12G10 to integrins αvβ1 and α5β1. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ## P < 0.01, ### P < 0.001).

    Journal: Bioactive Materials

    Article Title: Mechanically sensitized hydrogel microspheres trigger membrane receptor switch for cartilage repair

    doi: 10.1016/j.bioactmat.2026.03.017

    Figure Lengend Snippet: Integrin receptor activation induced by membrane receptor switch. A) The fluorescence microscopy of MSCs loaded on HAMA or OBNC hydrogel after different treatments. B) Relative fluorescence intensity in the whole field of view for each group. C) Relative fluorescence intensity per cell for each group (∗ symbol represents comparison with HAMA group, # symbol represents comparison with OBNC group). D) Flow cytometry was used to detect integrin αvβ1 and α5β1 positive cells. E) Relative fluorescence intensity of each group. F) Flow cytometry was used to detect 12G10 positive cells and within integrin αvβ1 and α5β1 positive cells. G) Relative fluorescence intensity of each group, and relative proportions of 12G10 to integrins αvβ1 and α5β1. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ## P < 0.01, ### P < 0.001).

    Article Snippet: TRPC1 inhibitor (0.3 nM, Pico145, CAS No. 1628287-16-0), TRPM7 inhibitor (1.0 μM, VPC4, CAS No. 945604-76-2), TRPV2 inhibitor (5.0 μM, compound IV2-1, CAS No. 2242724-49-6), TRPM4 inhibitor (1.5 μM, CBA, CAS No. 351424-20-9), PIEZO1 inhibitor (2.5 μM, GsMTx4, CAS No. 1209500-46-8), integrin αvβ5 inhibitor (8.0 nM, Compound 12, CAS No.: 2615912-33-7), integrin αvβ1 inhibitor (0.3 nM, Compound C8, CAS No. 1689540-62-2), integrin α5β1 inhibitor (10 μM, ATN-161, 904763-27-5), and CDK5 inhibitor (5 nM, CDK5-IN-1, 2,639,540-19-3) were purchased from MCE Biotechnology Co., LTD. After the MSCs were treated, the cRGD solution was added at a concentration of 1:200 and incubated in the dark for 15 min, and the results were observed by fluorescence microscopy.

    Techniques: Activation Assay, Membrane, Fluorescence, Microscopy, Comparison, Flow Cytometry